Table 1.
Baseline characteristics—no. (%) | N = 24 |
---|---|
Age, yearsa | 74.1 [61.8-87.9] |
Female gender | 16 (66.7) |
Anti-thrombotic therapy | |
Aspirin | 12 (50) |
Clopidogrel | 2 (8.3) |
Warfarin | 2 (8.3) |
Ischemic Stroke Presentation and Management—no. (%) | |
NIHSS Scorea | 12 [5 –19] |
Stroke onset to rt-PA treatment time, hoursa | 2.2 [1.6–2.7] |
Intravenous rt-PA—no. (%) | 24 (100) |
rt-PA initiated at OSH—no. (%) | 20 (83.3) |
Mechanical recanalization—no. (%) | 4 (16.7) |
Intra-arterial rt-PA—no. (%) | 1 (4.2) |
Laboratory Parameters Pre rt-PAa | |
Platelets, k/mm3 | 203 [161–303] |
INR | 1 [1–1.1] |
PT, seconds | 12.6 [11.2–13.4] |
aPTT, seconds | 28.4 [26.3–29.6] |
Glucose | 159 [110–199] |
Hemorrhage Presentation—no. (%) | |
Symptom onset at OSH | 8 (33.3) |
Time from rt-PA to hemorrhage confirmation, hoursa,b | 4.6 [3.3–6.0] |
Hemorrhage type | |
ICH | 22 (91.7) |
GIc | 2 (8.3) |
Groin puncture site | 1 (4.2) |
Time from hemorrhage confirmationb to fibrinogen concentrate administration, hoursa | 1.2 [0.5–2.3] |
Laboratory Parameters Post rt-PA Prior to Fibrinogen Concentratea | |
Fibrinogen, mg/dL | 256 [130–347] |
Platelets, k/mm3 | 197 [150–287] |
INR | 1.2 [1.1–1.6] |
PT, seconds | 15.1 [14.4–18.9] |
aPTT, seconds | 33.4 [27.8–39.6] |
Hematocrit, % | 37.4 [34.1–41.4] |
Hemoglobin, mg/dL | 12.6 [11–13.9] |
OSH: Outside hospital; ICH: Intracerebral Hemorrhage; GI: Gastrointestinal.
a Data presented as median [interquartile range.
b On radiographic imaging (ICH) or clinical presentation (gastrointestinal, groin puncture hemorrhage).
c One patient had concurrent ICH and GI bleed.